000 01569 a2200445 4500
005 20250518054817.0
264 0 _c20200903
008 202009s 0 0 eng d
022 _a1876-7737
024 7 _a10.1016/j.jprot.2019.103486
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGómez-Mendoza, Diana Paola
245 0 0 _aAngiotensin-(1-7) oral treatment after experimental myocardial infarction leads to downregulation of CXCR4.
_h[electronic resource]
260 _bJournal of proteomics
_c09 2019
300 _a103486 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Oral
650 0 4 _aAngiotensin I
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aDown-Regulation
_xdrug effects
650 0 4 _aMale
650 0 4 _aMitochondria, Heart
_xmetabolism
650 0 4 _aMyocardial Infarction
_xmetabolism
650 0 4 _aMyocardium
_xmetabolism
650 0 4 _aPeptide Fragments
_xpharmacology
650 0 4 _aProteome
_xmetabolism
650 0 4 _aProteomics
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aReceptors, CXCR4
_xbiosynthesis
700 1 _aMarques, Fúlvia Dias
700 1 _aMelo-Braga, Marcella Nunes
700 1 _aSprenger, Richard R
700 1 _aSinisterra, Rubén Dario
700 1 _aKjeldsen, Frank
700 1 _aSantos, Robson Augusto
700 1 _aVerano-Braga, Thiago
773 0 _tJournal of proteomics
_gvol. 208
_gp. 103486
856 4 0 _uhttps://doi.org/10.1016/j.jprot.2019.103486
_zAvailable from publisher's website
999 _c30029903
_d30029903